H.C. Wainwright initiated coverage on Prime Medicine with a new price target

5/20/24 7:24:41 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

H.C. Wainwright initiated coverage of Prime Medicine with a rating of Buy and set a new price target of $10.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PRME

Date	Price Target	Rating	Analyst
5/27/2025	$1.50	Buy → Neutral	Citigroup
5/20/2025		Overweight → Neutral	Analyst
5/20/2025		Buy → Neutral	H.C. Wainwright
12/10/2024	$10.00	Mkt Outperform	JMP Securities
5/20/2024	$10.00	Buy	H.C. Wainwright
5/16/2024	$10.00	Neutral → Buy	Citigroup
4/22/2024	$17.00	Buy	Chardan Capital Markets
4/8/2024		Buy	TD Cowen